New Delhi, Jan 21 || The Central Drugs Standard Control Organisation (CDSCO) on Wednesday declared 167 drug samples tested by the Central and state drugs regulatory authorities as ‘not of standard quality (NSQ)' in its monthly drug alert for December.
While the Central Drugs Laboratories identified 74 drug samples as NSQ, the State Drugs Testing Laboratories identified 93 drug samples as NSQ.
As per routine regulatory surveillance activity, the list of NSQ and spurious drugs is being displayed on the CDSCO portal on a monthly basis.
“For the month of December 2025, Central Drugs Laboratories have identified 74 Drug Samples to be Not of Standard Quality (NSQ) and State Drugs Testing Laboratories have identified 93 Drug Samples as Not of Standard Quality (NSQ),” the alert said.
Identification of drug samples as NSQ is done based on failure of the drug sample in one or more of the other specified quality parameters.
The failure is specific to the drug products of the batch tested by the government laboratory, and it does not warrant any concerns about the other drug products available in the market.